NeoGenomics Announces Chief Executive Officer Succession
Chris Smith to retire effective April 1, 2025; Board Member Tony Zook named incoming CEO Company reaffirms Fiscal 2024 financial guidance Press Release – January 10, 2025 – FT. MYERS, Fla. – NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ:NEO), a leading oncology testing services company, today announced that Chris Smith will retire as Chief Executive Officer (CEO) and board member effective April 1, 2025. Tony Zook, … Continue reading NeoGenomics Announces Chief Executive Officer Succession